Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging

Abstract The progressive increase of the aged population worldwide mandates new strategies to ensure sustained health and well-being with age. The development of better and/or new vaccines against pathogens that affect older adults is one pivotal intervention in approaching this goal. However, the f...

Full description

Bibliographic Details
Main Authors: Giuseppe Del Giudice, Jörg J. Goronzy, Beatrix Grubeck-Loebenstein, Paul-Henri Lambert, Tomas Mrkvan, Jeffrey J. Stoddard, T. Mark Doherty
Format: Article
Language:English
Published: Nature Portfolio 2017-12-01
Series:npj Aging and Mechanisms of Disease
Online Access:https://doi.org/10.1038/s41514-017-0020-0
_version_ 1831774008258854912
author Giuseppe Del Giudice
Jörg J. Goronzy
Beatrix Grubeck-Loebenstein
Paul-Henri Lambert
Tomas Mrkvan
Jeffrey J. Stoddard
T. Mark Doherty
author_facet Giuseppe Del Giudice
Jörg J. Goronzy
Beatrix Grubeck-Loebenstein
Paul-Henri Lambert
Tomas Mrkvan
Jeffrey J. Stoddard
T. Mark Doherty
author_sort Giuseppe Del Giudice
collection DOAJ
description Abstract The progressive increase of the aged population worldwide mandates new strategies to ensure sustained health and well-being with age. The development of better and/or new vaccines against pathogens that affect older adults is one pivotal intervention in approaching this goal. However, the functional decline of various physiological systems, including the immune system, requires novel approaches to counteract immunosenescence. Although important progress has been made in understanding the mechanisms underlying the age-related decline of the immune response to infections and vaccinations, knowledge gaps remain, both in the areas of basic and translational research. In particular, it will be important to better understand how environmental factors, such as diet, physical activity, co-morbidities, and pharmacological treatments, delay or contribute to the decline of the capability of the aging immune system to appropriately respond to infectious diseases and vaccination. Recent findings suggest that successful approaches specifically targeted to the older population can be developed, such as the high-dose and adjuvanted vaccines against seasonal influenza, the adjuvanted subunit vaccine against herpes zoster, as well as experimental interventions with immune-potentiators or immunostimulants. Learning from these first successes may pave the way to developing novel and improved vaccines for the older adults and immunocompromised. With an integrated, holistic vaccination strategy, society will offer the opportunity for an improved quality of life to the segment of the population that is going to increase most significantly in numbers and proportion over future decades.
first_indexed 2024-12-22T08:46:38Z
format Article
id doaj.art-a8ee1fc6f7b64f2390b32b767db0e7f4
institution Directory Open Access Journal
issn 2056-3973
language English
last_indexed 2024-12-22T08:46:38Z
publishDate 2017-12-01
publisher Nature Portfolio
record_format Article
series npj Aging and Mechanisms of Disease
spelling doaj.art-a8ee1fc6f7b64f2390b32b767db0e7f42022-12-21T18:32:06ZengNature Portfolionpj Aging and Mechanisms of Disease2056-39732017-12-01411810.1038/s41514-017-0020-0Fighting against a protean enemy: immunosenescence, vaccines, and healthy agingGiuseppe Del Giudice0Jörg J. Goronzy1Beatrix Grubeck-Loebenstein2Paul-Henri Lambert3Tomas Mrkvan4Jeffrey J. Stoddard5T. Mark Doherty6GSKStanford University School of MedicineUniversity of InnsbruckUniversity of GenevaGSKGSKGSKAbstract The progressive increase of the aged population worldwide mandates new strategies to ensure sustained health and well-being with age. The development of better and/or new vaccines against pathogens that affect older adults is one pivotal intervention in approaching this goal. However, the functional decline of various physiological systems, including the immune system, requires novel approaches to counteract immunosenescence. Although important progress has been made in understanding the mechanisms underlying the age-related decline of the immune response to infections and vaccinations, knowledge gaps remain, both in the areas of basic and translational research. In particular, it will be important to better understand how environmental factors, such as diet, physical activity, co-morbidities, and pharmacological treatments, delay or contribute to the decline of the capability of the aging immune system to appropriately respond to infectious diseases and vaccination. Recent findings suggest that successful approaches specifically targeted to the older population can be developed, such as the high-dose and adjuvanted vaccines against seasonal influenza, the adjuvanted subunit vaccine against herpes zoster, as well as experimental interventions with immune-potentiators or immunostimulants. Learning from these first successes may pave the way to developing novel and improved vaccines for the older adults and immunocompromised. With an integrated, holistic vaccination strategy, society will offer the opportunity for an improved quality of life to the segment of the population that is going to increase most significantly in numbers and proportion over future decades.https://doi.org/10.1038/s41514-017-0020-0
spellingShingle Giuseppe Del Giudice
Jörg J. Goronzy
Beatrix Grubeck-Loebenstein
Paul-Henri Lambert
Tomas Mrkvan
Jeffrey J. Stoddard
T. Mark Doherty
Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
npj Aging and Mechanisms of Disease
title Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
title_full Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
title_fullStr Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
title_full_unstemmed Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
title_short Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
title_sort fighting against a protean enemy immunosenescence vaccines and healthy aging
url https://doi.org/10.1038/s41514-017-0020-0
work_keys_str_mv AT giuseppedelgiudice fightingagainstaproteanenemyimmunosenescencevaccinesandhealthyaging
AT jorgjgoronzy fightingagainstaproteanenemyimmunosenescencevaccinesandhealthyaging
AT beatrixgrubeckloebenstein fightingagainstaproteanenemyimmunosenescencevaccinesandhealthyaging
AT paulhenrilambert fightingagainstaproteanenemyimmunosenescencevaccinesandhealthyaging
AT tomasmrkvan fightingagainstaproteanenemyimmunosenescencevaccinesandhealthyaging
AT jeffreyjstoddard fightingagainstaproteanenemyimmunosenescencevaccinesandhealthyaging
AT tmarkdoherty fightingagainstaproteanenemyimmunosenescencevaccinesandhealthyaging